Shanghai Obio Technology (Group) (SHSE:688238) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 29, 2026)


SHSE:688238 Shanghai Obio Technology (Group) Corp Ltd SHSE:688238
63 GF Score
Price ¥5.48
GF Value ¥7.77
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Obio Technology (Group) Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Shanghai Obio Technology (Group)'s Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

SHSE:688238 vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Shanghai Obio Technology (Group)'s Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Obio Technology (Group) Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Obio Technology (Group)'s Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Shanghai Obio Technology (Group)'s Margin of Safety % (DCF FCF Based) falls into.


SHSE:688238
63GF Score
Shanghai Obio Technology (Group) Corp Ltd SHSE:688238
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Obio Technology (Group) (SHSE:688238) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Obio Technology (Group) stock appears to be undervalued. The current stock price of ¥5.48 is trading 29.5% below its estimated GF Value™ of ¥7.77. GuruFocus considers Shanghai Obio Technology (Group) to be Modestly Undervalued.

Key valuation signals for SHSE:688238:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ¥7.77 vs. price of ¥5.48 (29.5% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688238 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Obio Technology (Group) Business Description

Address Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201318
Shanghai Obio Technology (Group) Corp Ltd provides contract research organization (CRO) services, including gene therapy vector development and gene function research for basic research, as well as contract development and manufacturing organization (CDMO) services, including IND-enabling CMC research and GMP production of clinical samples for gene therapy drug development.
63GF Score

Get the complete analysis for SHSE:688238

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.48
Price
¥7.77
GF Value